Starboard Value
Starboard Value LP is a New York-based investment adviser with a focused and differentiated fundamental approach to investing in publicly traded U.S. small cap companies. Starboard invests in deeply undervalued small cap companies and actively engages with management teams and boards of directors to identify and execute on opportunities to unlock value for the benefit of all shareholders.
View Older Stories View More Recent Stories
-
EBay raises forecast as redesign draws customers, boosts ad revenue
-
Cars.com (CARS) Sales Process Stalls, But May Sputter to Finish Line - Sources
-
Cars.com (CARS) Extends Deadline for Board Nomination, Continues to Explore Strategic Alternatives
-
Cars.com Extends Deadline for Nomination of Directors for the 2019 Annual Meeting of Stockholders
-
Starboard takes new position in KAR Auction Services
-
PlacementTracker Publishes Q1 2019 PIPE and Private Placement Markets League Tables
-
Bristol-Myers says shareholders vote to approve Celgene takeover
-
Exclusive: EQT, Digital Colony, Stonepeak group near deal to buy Zayo - sources
-
Cerner (CERN) PT Raised to $77 at Citi
-
Cerner settles with hedge fund Starboard: to add new directors, increase buybacks
-
Pre-Open Stock Movers 04/09: (PHAS) (CERN) (AVYA) Higher; (ZGNX) (ZSAN) (DARE) Lower (more...)
-
Cerner (CERN) Announces Pact with Starboard Value on Board Refreshment, Operational Improvement Initiatives and Expanded Capital Returns
-
Cerner Announces Agreement with Starboard Value Regarding Board Refreshment, Operational Improvement Initiatives and Expanded Capital Return Program to Drive Next Phase of Profitable Growth and Value
-
Cerner Announces Agreement with Starboard Value Regarding Board Refreshment, Operational Improvement Initiatives and Expanded Capital Return Program to Drive Next Phase of Profitable Growth and Value
-
Former ISS marketing manager turns corporate governance consultant
-
UPDATE: Loop Capital Downgrades Dollar Tree (DLTR) to Hold
-
Starboard drops Dollar Tree board challenge
-
Dollar Tree Comments on Starboard Value’s Withdrawal of Nominees
-
Starboard Releases Statement on Dollar Tree
-
Form SC 13D/A PAPA JOHNS INTERNATIONAL Filed by: Starboard Value LP
-
Form SC 13D/A MAGELLAN HEALTH INC Filed by: Starboard Value LP
-
Form DFAN14A BRISTOL MYERS SQUIBB CO Filed by: Starboard Value LP
-
Starboard to withdraw its proxy solicitation to vote against the Celgene (CELG)/Bristol-Myers (BMY) deal
-
Starboard Issues Statement on Bristol-Myers
-
Starboard abandons campaign to scuttle Bristol-Myers-Celgene deal
-
Magellan Health (MGLN) Enters Pact with Starboard
-
Magellan Health Announces Agreement with Starboard
-
Exclusive: Magellan Health nears board deal with hedge fund Starboard Value - sources
-
Magellan Health (MGLN) nears settlement with Starboard Value - Reuters
-
Form DFAN14A BRISTOL MYERS SQUIBB CO Filed by: Starboard Value LP
-
Starboard Mails Letter to All Bristol-Myers Squibb Shareholders
-
Cars.com Inc. (CARS) Extends Deadline for Nomination of Directors Following Discussions with Starboard Value L.P
-
Cars.com Extends Deadline for Nomination of Directors for the 2019 Annual Meeting of Stockholders
-
Bristol-Myers Squibb (BMY) Board Provides Open Letter Shareholder Regarding Merger Agreement with Celgene Corp. (CELG)
-
Bristol-Myers Squibb Board of Directors Sends Letter to Shareholders Highlighting the Compelling Strategic and Financial Rationale of the Celgene Transaction; Company Provides Additional Investor Mate
-
Form DFAN14A BRISTOL MYERS SQUIBB CO Filed by: Starboard Value LP
-
Former NBA star Shaquille O'Neal joins Papa John's board
-
Papa John's (PZZA) Names Shaquille O'Neal to Board; Announces O'Neal as Brand Ambassador & Investor in 9 Atlanta, GA Restaurant Locations
-
Papa John’s and Shaquille O’Neal Enter New Partnership
-
Morgan Stanley holds top spot as activist defense firm: data
-
Form DFAN14A BRISTOL MYERS SQUIBB CO Filed by: Starboard Value LP
-
Starboard Issues Investor Presentation Opposing Bristol-Myers Squibb's (BMY) Ill-Advised Proposed Acquisition of Celgene (CELG)
-
Bristol-Myers Squibb (BMY) Highlights Significant Benefits of Pending Transaction with Celgene (CELG)
-
Starboard Issues Investor Presentation Opposing Bristol-Myers Squibb's Ill-Advised Proposed Acquisition of Celgene
-
Bristol-Myers Squibb Files Investor Presentation Highlighting Significant Benefits of Pending Transaction with Celgene
-
Form DFAN14A BRISTOL MYERS SQUIBB CO Filed by: Starboard Value LP
-
Form DEFC14A BRISTOL MYERS SQUIBB CO Filed by: Starboard Value LP
-
Mutual funds start to put their mouth where their money is
-
Newell Brands CEO Polk to retire
-
Form PRRN14A BRISTOL MYERS SQUIBB CO Filed by: Starboard Value LP


